A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Kyowa Hakko Kirin
- 10 Jun 2017 Biomarkers information updated
- 15 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jul 2010 New trial record